Climb Bio, Inc.
CLYM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768446
In the last 90 days, Climb Bio, Inc. insiders filed 0 open-market purchases and 1 sale; 108 institutions reported holding it in 13F filings for Q2 2026, worth $734.3M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Climb Bio, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 80 | 1 | 76 | −3 |
| Shares | 55.7M | 39.0K | 51.9M | −3.73M (−6.7%) |
| Value | $100.3M | $70.3K | $63.4M | −$36.8M (−36.8%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Climb Bio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 1,000,000 | $1.22M | 0.07% |
| Peapod Lane Capital LLC | 553,816 | $675.7K | 0.76% |
| Shay Capital LLC | 200,000 | $244.0K | 0.07% |
| Bridgeway Capital Management, LLC | 134,300 | $163.8K | 0.00% |
| Millennium Management LLC | 63,379 | $77.3K | 0.00% |
| Nuveen, LLC | 39,034 | $47.6K | 0.00% |
| XTX Topco Ltd | 27,660 | $33.7K | 0.00% |
| JustInvest LLC | 15,225 | $18.6K | 0.00% |
| Coldstream Capital Management Inc | 336 | $410 | 0.00% |
| True Wealth Design, LLC | 12 | $15 | 0.00% |
| EverSource Wealth Advisors, LLC | 9 | $11 | 0.00% |
Sold out (14)
Institutions that held Climb Bio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Janus Henderson Group PLC | 3,184,200 | $5.72M |
| Samsara BioCapital, LLC | 2,609,114 | $4.70M |
| Ally Bridge Group (NY) LLC | 760,225 | $1.37M |
| Parkman Healthcare Partners LLC | 290,491 | $522.9K |
| Segall Bryant & Hamill, LLC | 123,956 | $223.1K |
| Superstring Capital Management LP | 98,160 | $176.7K |
| Walleye Capital LLC | 62,039 | $111.7K |
| Bailard, Inc. | 56,800 | $102.2K |
| Squarepoint Ops LLC | 30,845 | $55.5K |
| American Century Companies Inc | 13,684 | $24.6K |
| Virtu Financial LLC | 11,733 | $21.0K |
| ProShare Advisors LLC | 11,469 | $20.6K |
| R Squared Ltd | 1,330 | $2.39K |
| Nisa Investment Advisors, LLC | 227 | $409 |
Not filed for Q1 2025 yet (1)
Institutions that held Climb Bio, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 39,034 | $70.3K |